Hims & Hers Health, Inc. (HIMS)

Market Cap	4.38B
Revenue (ttm)	959.40M
Net Income (ttm)	-2.35M
Shares Out	206.41M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	109.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,329,269
Open	21.29
Previous Close	21.42
Day's Range	20.53 - 21.97
52-Week Range	5.65 - 25.74
Beta	1.08
Analysts	Buy
Price Target	16.92 (-20.23%)
Earnings Date	Aug 5, 2024

About HIMS

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supp...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2017
• Employees: 1,046
• Stock Exchange: NYSE
• Ticker Symbol: HIMS

Financial Performance

In 2023, HIMS's revenue was $872.00 million, an increase of 65.49% compared to the previous year's $526.92 million. Losses were -$23.55 million, -64.15% less than in 2022.

Analyst Forecast

According to 12 analysts, the average rating for HIMS stock is "Buy." The 12-month stock price forecast is $16.92, which is a decrease of -20.23% from the latest price.

Price Target

$16.92

(-20.23% downside)

Analyst Consensus: Buy